Literature DB >> 18432770

Monoclonal antibody supernatant and ascites fluid production.

W M Yokoyama1.   

Abstract

Procedures detailing the production of monoclonal antibody supernatants, including the production of larger amounts (liters), are presented here. The protocol for large-scale production of hybridomas or cells (e.g., for isolation of cellular proteins) involves a similar procedure. A method for producing and obtaining ascites fluid containing the monoclonal antibody is also presented. The unit ends with a set of recommendations developed by the Committee on Methods of Producing Monoclonal Antibodies (Institute of Laboratory Animal Research, National Research Council). The recommendations are designed to foster the judicious use of animals for the production of monoclonal antibodies and to strongly encourage the use of in vitro methods whenever possible.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 18432770     DOI: 10.1002/0471142735.im0206s40

Source DB:  PubMed          Journal:  Curr Protoc Immunol        ISSN: 1934-3671


  2 in total

1.  Characterization of an isotype-dependent monoclonal antibody against linear neutralizing epitope effective for prophylaxis of enterovirus 71 infection.

Authors:  Xiao Fang Lim; Qiang Jia; Wei Xin Khong; Benedict Yan; Balraj Premanand; Sylvie Alonso; Vincent T K Chow; Jimmy Kwang
Journal:  PLoS One       Date:  2012-01-18       Impact factor: 3.240

2.  Application of the Protein Maker as a platform purification system for therapeutic antibody research and development.

Authors:  Geneviève Hélie; Marie Parat; Frédéric Massé; Cory J Gerdts; Thomas P Loisel; Allan Matte
Journal:  Comput Struct Biotechnol J       Date:  2016-06-16       Impact factor: 7.271

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.